Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer
暂无分享，去创建一个
F. Pontén | K. Edlund | K. Jirström | Ö. Türeci | U. Şahin | J. Hengstler | S. Ekman | A. Berglund | J. Mattsson | P. Micke | J. Botling | Miriam Lohr | Stefan Wöll | M. Marincevic | Jörg Rahnenfuehrer | S. Wöll